- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr John Santopietro Describes the Stigma Barrier to Behavioral Health Issues
The intersection of mental and physical health has been around now for quite some time, but the stigma attached to behavioral issues remains a barrier to patients getting the help they need, according to John Santopietro MD.
The intersection of mental and physical health has been around now for quite some time, but the stigma attached to behavioral issues remains a barrier to patients getting the help they need, according to John Santopietro MD, chief clinical officer of behavioral health at Carolinas HealthCare System.
“Stigma keeps people from wanting to talk with their doctors about what’s going,” Dr Santopietro said. “Stigma keeps us from investing in mental health research in the way that we need to and it affects communities and institutions.”
He added that facing stigma head on, rather than turning away from it, is an approach that needs to be taken at large.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
